New NIBRT Training Case Study with WuXi Biologics

NIBRT are pleased to publish our most recent training case study featuring WuXi Biologics.

This case study provides a good flavour of what trainees can expect when you attend a training course at NIBRT. Hear from WuXi Biologics trainees on their experience of our training facilities and trainers.

About WuXi Biologics

WuXi Biologics is a leading global biologics CRDMO (Contract Research, Development and Manufacturing Organisation) offering end-to-end solutions which enable partners to discover, develop and manufacture biologics from concept to commercial manufacturing for the benefit of patients worldwide.

What training has NIBRT provided to WuXi Biologics?

NIBRT has delivered a number of customised training courses to WuXi Biologics staff over the last two years, both online and onsite in NIBRT. Courses have included manufacturing from inoculum through to upstream and downstream processing to highly customised courses in Quality Control.

The attendees interviewed for the purpose of this case study work in downstream processing. The course was delivered in online lectures for 3 days followed by 3 days practical study at NIBRT. These practicals were carried out in NIBRT’s pilot plant and lab facility with sessions customised to WuXi Biologics processes and unit operations.

How did participants rate training at NIBRT?

9/10 overall course experience average

100% of trainees rated our trainers 9/10 or above

85% of trainees would likely recommend this course to a friend

What did trainees say about NIBRT?

Caoimhe Duffy – Bioprocess Associate; “The training today was great. It was great to see the equipment first hand and get the experience from it because I am normally more theory and desk based’’

James Downey – Bioprocess Associate; “I would definitely recommend the downstream processing course in NIBRT as it gives very in depth practical and theoretical knowledge of the downstream process’

Ross Halpin – Finite Scheduler; ‘’As a Finite Scheduler and new to the business of biopharma it is going to benefit me in learning different parts of the process and how the process actually works’’.